SEOUL, South Korea and RIYADH, Saudi Arabia /PRNewswire/ -- Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-Jae Lee) ...
South Korean pharmaceutical and biotechnology companies are on edge as U.S. President Donald Trump signals the introduction ...
Daewoong Pharmaceutical achieves record revenue and operating profit in 2022 Daewoong Pharmaceutical sets new performance ...
Medical Spa RX, a trusted name in medical and aesthetic supplies, now offers Re N Tox, a cutting-edge botulinum toxin type A ...
Daewoong Pharmaceutical officially launched its botulinum toxin (botox) product 'Nabota' in Saudi Arabia on the 31st.
Authorities have uncovered a criminal network trafficking illegal medical substances used in aesthetic treatments, prompting the investigation of 24 clinics across multiple regions. The Guardia Civil, ...
As recognized with approvals from the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and Health Canada, Daewoong Pharmaceutical's botulinum toxin has demonstrated ...